Diligent Investors, LLC Bristol Myers Squibb CO Transaction History

Diligent Investors, LLC

$372 Million
Q2 2024

A detailed history of Diligent Investors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Diligent Investors, LLC holds 10,498 shares of BMY stock, worth $568,781. This represents 0.12% of its overall portfolio holdings.

Number of Shares

10,498

Previous 10,638 1.32%

Holding current value

$568,781

Previous $576,000 24.48%

% of portfolio

0.12%

Previous 0.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$40.25 - $52.99 $5,635 - $7,418	-140 Reduced 1.32%	10,498 $435,000
Q1 2024 May 03, 2024	SELL	$47.98 - $54.4 $11,995 - $13,600	-250 Reduced 2.3%	10,638 $576,000
Q4 2023 Jan 10, 2024	SELL	$48.48 - $57.85 $11,247 - $13,421	-232 Reduced 2.09%	10,888 $558,000
Q3 2023 Nov 03, 2023	SELL	$57.89 - $64.73 $7,352 - $8,220	-127 Reduced 1.13%	11,120 $645,000
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $22,932 - $26,010	349 Added 3.2%	11,247 $779,000
Q4 2022 Jan 20, 2023	SELL	$68.48 - $81.09 $13,696 - $16,218	-200 Reduced 1.8%	10,898 $0
Q3 2022 Oct 14, 2022	SELL	$0.13 - $76.84 $41 - $24,281	-316 Reduced 2.77%	11,098 $789,000
Q2 2022 Jul 13, 2022	SELL	$72.62 - $79.98 $10,529 - $11,597	-145 Reduced 1.25%	11,414 $879,000
Q1 2022 Apr 26, 2022	SELL	$61.48 - $73.72 $24,223 - $29,045	-394 Reduced 3.3%	11,559 $844,000
Q4 2021 Jan 21, 2022	SELL	$53.63 - $62.52 $13,192 - $15,379	-246 Reduced 2.02%	11,953 $745,000
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $12,072 - $13,146	-195 Reduced 1.57%	12,199 $815,000
Q1 2021 Apr 23, 2021	BUY	$59.34 - $66.74 $2,610 - $2,936	44 Added 0.36%	12,394 $782,000
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $17,437 - $19,759	302 Added 2.51%	12,350 $766,000
Q3 2020 Nov 09, 2020	SELL	$57.43 - $63.64 $32,045 - $35,511	-558 Reduced 4.43%	12,048 $726,000
Q2 2020 Jul 09, 2020	BUY	$54.82 - $64.09 $26,971 - $31,532	492 Added 4.06%	12,606 $741,000
Q1 2020 Apr 29, 2020	SELL	$46.4 - $67.43 $20,833 - $30,276	-449 Reduced 3.57%	12,114 $675,000
Q4 2019 Jan 13, 2020	SELL	$49.21 - $64.19 $13,237 - $17,267	-269 Reduced 2.1%	12,563 $806,000
Q3 2019 Oct 22, 2019	SELL	$42.77 - $50.71 $21,598 - $25,608	-505 Reduced 3.79%	12,832 $651,000
Q2 2019 Aug 01, 2019	SELL	$44.62 - $49.34 $23,559 - $26,051	-528 Reduced 3.81%	13,337 $605,000
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $10,106 - $12,051	-224 Reduced 1.59%	13,865 $661,000
Q4 2018 Jan 17, 2019	SELL	$48.76 - $63.23 $1,462 - $1,896	-30 Reduced 0.21%	14,089 $732,000
Q3 2018 Oct 26, 2018	SELL	$55.19 - $62.25 $45,310 - $51,107	-821 Reduced 5.5%	14,119 $877,000
Q2 2018 Jul 23, 2018	SELL	$50.53 - $62.98 $16,068 - $20,027	-318 Reduced 2.08%	14,940 $827,000
Q1 2018 Apr 23, 2018	SELL	$59.92 - $68.98 $17,796 - $20,487	-297 Reduced 1.91%	15,258 $965,000
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $179 - $196	3 Added 0.02%	15,555 $953,000
Q3 2017 Nov 09, 2017	SELL	$55.23 - $63.74 $79,973 - $92,295	-1,448 Reduced 8.52%	15,552 $991,000
Q2 2017 Aug 11, 2017	BUY	N/A	17,000	17,000 $947,000

Others Institutions Holding BMY

# of Institutions

2,404

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diligent Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diligent Investors, LLC with notifications on news.

Account

Diligent Investors, LLC Bristol Myers Squibb CO Transaction History